BLOG
Advancing Early Cancer Diagnosis through Liquid Biopsy and Circulating Tumor Cells
Late-stage cancer diagnosis often limits treatment options and leads to unfavorable outcomes. Patients with metastatic solid cancers face limited curative options, underscoring the importance of early neoplasia detection for improved outcomes. Histopathology has long...
Unraveling Obesity’s Link to Colorectal Cancer
Obesity is a well-known risk factor for colorectal cancer, but the exact connections between the two conditions are not fully understood. A groundbreaking project is using untargeted metabolomics, focusing on small molecules, to uncover the 'metabolic signatures'...
A Plant-Based Diet May Lower the Risk of Prostate Cancer Progression and Recurrence
A plant-based diet may lower the risk of prostate cancer progression and recurrence, according to a new study presented at the 2023 ASCO Genitourinary Cancers Symposium. The study involved participants enrolled in the Cancer of the Prostate Strategic Urologic Research...
Are Dense Breasts a Risk Factor for Breast Cancer?
All breasts are different…that’s what we’ve always been told, but do you know just how different they can be and what that means for your breast cancer risk? The one thing we all have in common is that breasts are made up of the same materials; glandular, connective,...
Iron Infusions: What you Need to Know
Iron-deficiency is a common condition in which the body doesn't have enough iron to produce hemoglobin, the protein in red blood cells that carries oxygen throughout the body. This can lead to symptoms such as fatigue, weakness, and shortness of breath. Fortunately,...
Leafy Greens – Your Allies in the Fight Against Bowel Cancer
In a recent groundbreaking study funded by the World Cancer Research Fund, the connection between folate-rich diets and a reduced risk of bowel (colorectal) cancer has taken center stage. Published in the American Journal of Clinical Nutrition, the research, led by...
The Importance of Inclusivity in Cancer Care for the LGBTQIA+ Community
The standard of care that one expects when facing a crisis such as cancer is not always met for those in the LGBTQ+ community. A problem that not only creates shame / mental health issues, but can lead to death. A recent symposium hosted by Cedars-Sinai addressed this...
Your Prostate, Your Priority
In the realm of royal health, King Charles has unwittingly become the poster child for prostate awareness. The announcement of his upcoming procedure to treat an enlarged prostate and cancer diagnosis has not only sent shockwaves through Buckingham Palace but has also...
AI – A Revolutionary Approach to Predicting Cancer Responses
In a groundbreaking study, researchers at the University of California San Diego School of Medicine have harnessed the capabilities of artificial intelligence (AI) to predict when cancer may resist chemotherapy. This cutting-edge AI tool offers a glimpse into the...
Unlocking the Benefits of Testosterone
Despite the proven benefits of replacement therapy, only about 20% of patients withsymptomatic low testosterone levels receive treatment. Let's delve into the challenges patientsface – from under-diagnosis to reluctant doctors – and explore the proven advantages...
The Importance of Nutrition for Skincare and Aging
Anti-aging has been a popular topic for as long as we can remember, people are always striving to stay looking young and youthful for as long as possible. However, there is much debate as to the best ways to do this, but one factor that can be agreed upon is...
Plant Protein: The Star Player in Healthy Aging in Women
Aging gracefully isn't just about adding years; it's about ensuring those years are lived healthily and free from chronic conditions. A recent study from Tufts University sheds light on a vital piece of the puzzle: the role of protein, especially plant-based protein,...
Successful Treatment of Advanced Ovarian Cancer with Thermochemotherapy and Adjuvant Immune Therapy
We report on a 4-year progression-free survival of a 54-year-old female first diagnosed in December 2007 with advanced bilateral ovarian cancer FIGO IIIc, disseminated peritoneal carcinosis and malignant diaphragm invasion. Treatment started in January 2008 with 6...
Whole-Body Hyperthermia in Combination with Platinum-Containing Drugs in Patients with Recurrent Ovarian Cancer.
BackgroundPatients with advanced ovarian cancer have an enormous risk of relapse after primary therapy, and the prognosis for these patients remains bleak. Primary and acquired resistance of tumor cells to antineoplastic drugs is a major cause of the limited...
Sorafenib and Locoregional Deep Electro-Hyperthermia in Advanced Hepatocellular Carcinoma: A Phase II Study
The standard treatment for advanced hepatocellular carcinoma (HCC) is sorafenib, a multikinase inhibitor of tumor cell proliferation and angiogenesis. Hyperthermia inhibits angiogenesis and promotes apoptosis. Potential synergic antiangiogenic and proapoptotic effects...
Neo-adjuvant Chemotherapy Alone or With Regional Hyperthermia for Localised High-Risk Soft-Tissue Sarcoma: A Randomised Phase 3 Multicentre Study
Background The optimum treatment for high-risk soft-tissue sarcoma (STS) in adults is unclear. Regional hyperthermia concentrates the action of chemotherapy within the heated tumour region. Phase 2 studies have shown that chemotherapy with regional hyperthermia...
Hyperthermia with Radiation in the Treatment of Locally Advanced Head and Neck Cancer: A Report of Randomized Trial
Background: Head and neck cancer is the leading cause of male mortality due to cancer in India. Surgery, radiation alone or in combination has been the backbone of treatment strategies. Chemo-radiation has emerged as the standard of care in most types of head and neck...
Hyperthermia as an Adjuvant to Radiation Therapy of Recurrent or Metastatic Malignant Melanoma. A Multicentre Randomized Trial by the European Society for Hyperthermic Oncology
The ESHO protocol 3-85 is a multicentre randomized trial investigating the value of hyperthermia as an adjuvant to radiotherapy in treatment of malignant melanoma. A total of 134 metastatic of recurrent malignant melanoma lesions in 70 patients were randomized to...
